{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:53:50Z","timestamp":1793051630981,"version":"4.5.0"},"publisher-location":"Cham","reference-count":114,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031261626","type":"print"},{"value":"9783031261633","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-26163-3_11","type":"book-chapter","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:03:29Z","timestamp":1682323409000},"page":"201-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Upregulation of CCL5\/RANTES Gene Expression in the Diaphragm of Mice with Cholestatic Liver Disease"],"prefix":"10.1007","author":[{"given":"Vania","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cabello-Verrugio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"3","key":"11_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00223-014-9915-y","volume":"96","author":"WR Frontera","year":"2015","unstructured":"Frontera WR, Ochala J (2015) Skeletal muscle: a brief review of structure and function. Calcif Tissue Int 96(3):183\u2013195. https:\/\/doi.org\/10.1007\/s00223-014-9915-y","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"11_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1462","volume":"12","author":"K Mukund","year":"2020","unstructured":"Mukund K, Subramaniam S (2020) Skeletal muscle: a review of molecular structure and function, in health and disease. Wiley Interdiscip Rev Syst Biol Med 12(1):e1462. https:\/\/doi.org\/10.1002\/wsbm.1462","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"12","key":"11_CR3","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.bpj.2020.11.005","volume":"119","author":"LF de Souza","year":"2020","unstructured":"de Souza LF, Rassier DE (2020) Sarcomere length nonuniformity and force regulation in myofibrils and sarcomeres. Biophys J 119(12):2372\u20132377. https:\/\/doi.org\/10.1016\/j.bpj.2020.11.005","journal-title":"Biophys J"},{"key":"11_CR4","doi-asserted-by":"publisher","unstructured":"Prill K, Dawson JF (2020) Assembly and maintenance of sarcomere thin filaments and associated diseases. Int J Mol Sci 21(2). https:\/\/doi.org\/10.3390\/ijms21020542","DOI":"10.3390\/ijms21020542"},{"issue":"7","key":"11_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/asj.13226","volume":"90","author":"K Ojima","year":"2019","unstructured":"Ojima K (2019) Myosin: formation and maintenance of thick filaments. Anim Sci J 90(7):801\u2013807. https:\/\/doi.org\/10.1111\/asj.13226","journal-title":"Anim Sci J"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.freeradbiomed.2016.03.025","volume":"98","author":"R Qaisar","year":"2016","unstructured":"Qaisar R, Bhaskaran S, Van Remmen H (2016) Muscle fiber type diversification during exercise and regeneration. Free Radic Biol Med 98:56\u201367. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.03.025","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"11_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/wdev.230","volume":"5","author":"J Talbot","year":"2016","unstructured":"Talbot J, Maves L (2016) Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease. Wiley Interdiscip Rev Dev Biol 5(4):518\u2013534. https:\/\/doi.org\/10.1002\/wdev.230","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"11_CR8","doi-asserted-by":"publisher","unstructured":"Pedersen BK, Akerstrom TC, Nielsen AR, Fischer CP (2007) Role of myokines in exercise and metabolism. J Appl Physiol 103(3):1093\u20131098 (1985). https:\/\/doi.org\/10.1152\/japplphysiol.00080.2007","DOI":"10.1152\/japplphysiol.00080.2007"},{"issue":"2\u20133","key":"11_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/a:1026070911202","volume":"24","author":"BK Pedersen","year":"2003","unstructured":"Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P et al (2003) Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 24(2\u20133):113\u2013119. https:\/\/doi.org\/10.1023\/a:1026070911202","journal-title":"J Muscle Res Cell Motil"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fphys.2019.00042","volume":"10","author":"JH Lee","year":"2019","unstructured":"Lee JH, Jun HS (2019) Role of myokines in regulating skeletal muscle mass and function. Front Physiol 10:42. https:\/\/doi.org\/10.3389\/fphys.2019.00042","journal-title":"Front Physiol"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fendo.2017.00097","volume":"8","author":"BP Carson","year":"2017","unstructured":"Carson BP (2017) The potential role of contraction-induced myokines in the regulation of metabolic function for the prevention and treatment of type 2 diabetes. Front Endocrinol (Lausanne) 8:97. https:\/\/doi.org\/10.3389\/fendo.2017.00097","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11_CR12","doi-asserted-by":"publisher","unstructured":"Hoffmann C, Weigert C (2017) Skeletal muscle as an endocrine organ: the role of myokines in exercise adaptations. Cold Spring Harb Perspect Med 7(11). https:\/\/doi.org\/10.1101\/cshperspect.a029793","DOI":"10.1101\/cshperspect.a029793"},{"issue":"Pt 23","key":"11_CR13","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.1113\/jphysiol.2009.179515","volume":"587","author":"BK Pedersen","year":"2009","unstructured":"Pedersen BK (2009) The diseasome of physical inactivity\u2013and the role of myokines in muscle\u2013fat cross talk. J Physiol 587(Pt 23):5559\u20135568. https:\/\/doi.org\/10.1113\/jphysiol.2009.179515","journal-title":"J Physiol"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fphys.2019.00287","volume":"10","author":"R Piccirillo","year":"2019","unstructured":"Piccirillo R (2019) Exercise-Induced myokines with therapeutic potential for muscle wasting. Front Physiol 10:287. https:\/\/doi.org\/10.3389\/fphys.2019.00287","journal-title":"Front Physiol"},{"issue":"8","key":"11_CR15","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.metabol.2013.04.008","volume":"62","author":"SA Polyzos","year":"2013","unstructured":"Polyzos SA, Kountouras J, Shields K, Mantzoros CS (2013) Irisin: a renaissance in metabolism? Metabolism 62(8):1037\u20131044. https:\/\/doi.org\/10.1016\/j.metabol.2013.04.008","journal-title":"Metabolism"},{"issue":"7382","key":"11_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC et al (2012) A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481(7382):463\u2013468. https:\/\/doi.org\/10.1038\/nature10777","journal-title":"Nature"},{"key":"11_CR17","doi-asserted-by":"publisher","unstructured":"Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Bel\u00e9n Crujeiras A et al (2013) FNDC5\/irisin is not only a myokine but also an adipokine. PloS One 8(4):e60563-e. https:\/\/doi.org\/10.1371\/journal.pone.0060563","DOI":"10.1371\/journal.pone.0060563"},{"issue":"1","key":"11_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12272-017-0994-y","volume":"41","author":"JY Huh","year":"2018","unstructured":"Huh JY (2018) The role of exercise-induced myokines in regulating metabolism. Arch Pharmacal Res 41(1):14\u201329. https:\/\/doi.org\/10.1007\/s12272-017-0994-y","journal-title":"Arch Pharmacal Res"},{"issue":"6","key":"11_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nrendo.2016.221","volume":"13","author":"N Perakakis","year":"2017","unstructured":"Perakakis N, Triantafyllou GA, Fern\u00e1ndez-Real JM, Huh JY, Park KH, Seufert J et al (2017) Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol 13(6):324\u2013337. https:\/\/doi.org\/10.1038\/nrendo.2016.221","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"11_CR20","doi-asserted-by":"publisher","first-page":"E1244","DOI":"10.1152\/ajpendo.00600.2009","volume":"298","author":"G Barbatelli","year":"2010","unstructured":"Barbatelli G, Murano I, Madsen L, Hao Q, Jimenez M, Kristiansen K et al (2010) The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am J Physiol-Endocrinol Metab 298(6):E1244\u2013E1253. https:\/\/doi.org\/10.1152\/ajpendo.00600.2009","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"1","key":"11_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4161\/adip.27370","volume":"3","author":"F Sanchis-Gomar","year":"2014","unstructured":"Sanchis-Gomar F, Perez-Quilis C (2014) The p38\u2013PGC-1\u03b1\u2013irisin\u2013betatrophin axis. Adipocyte 3(1):67\u201368. https:\/\/doi.org\/10.4161\/adip.27370","journal-title":"Adipocyte"},{"key":"11_CR22","doi-asserted-by":"publisher","unstructured":"Zhao M, Zhou X, Yuan C, Li R, Ma Y, Tang X (2020) Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study. Sci Rep 10(1):16093. https:\/\/doi.org\/10.1038\/s41598-020-73176-z","DOI":"10.1038\/s41598-020-73176-z"},{"key":"11_CR23","doi-asserted-by":"publisher","unstructured":"Reza MM, Subramaniyam N, Sim CM, Ge X, Sathiakumar D, McFarlane C et al (2017) Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy. Nat Commun 8(1):1104. https:\/\/doi.org\/10.1038\/s41467-017-01131-0","DOI":"10.1038\/s41467-017-01131-0"},{"issue":"8","key":"11_CR24","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3390\/nu12082401","volume":"12","author":"J Baczek","year":"2020","unstructured":"Baczek J, Silkiewicz M, Wojszel ZB (2020) Myostatin as a biomarker of muscle wasting and other pathologies-state of the art and knowledge gaps. Nutrients 12(8):2401. https:\/\/doi.org\/10.3390\/nu12082401","journal-title":"Nutrients"},{"issue":"47","key":"11_CR25","doi-asserted-by":"publisher","first-page":"12448","DOI":"10.1073\/pnas.1707925114","volume":"114","author":"F Morvan","year":"2017","unstructured":"Morvan F, Rondeau J-M, Zou C, Minetti G, Scheufler C, Scharenberg M et al (2017) Blockade of activin type II receptors with a dual anti-ActRIIA\/IIB antibody is critical to promote maximal skeletal muscle hypertrophy. Proc Natl Acad Sci 114(47):12448. https:\/\/doi.org\/10.1073\/pnas.1707925114","journal-title":"Proc Natl Acad Sci"},{"issue":"6628","key":"11_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387(6628):83\u201390. https:\/\/doi.org\/10.1038\/387083a0","journal-title":"Nature"},{"key":"11_CR27","doi-asserted-by":"publisher","unstructured":"Mosher DS, Quignon P, Bustamante CD, Sutter NB, Mellersh CS, Parker HG et al (2007) A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet 3(5):e79-e. https:\/\/doi.org\/10.1371\/journal.pgen.0030079","DOI":"10.1371\/journal.pgen.0030079"},{"key":"11_CR28","doi-asserted-by":"crossref","unstructured":"Gomarasca M, Banfi G, Lombardi G (2020) Myokines: the endocrine coupling of skeletal muscle and bone. In: Makowski GS (ed) Advances in clinical chemistry (chapter four). Elsevier, pp 155\u2013218","DOI":"10.1016\/bs.acc.2019.07.010"},{"key":"11_CR29","doi-asserted-by":"crossref","unstructured":"Chung HS, Choi KM (2020) Organokines in disease. In: Makowski GS (ed) Advances in clinical chemistry (chapter six). Elsevier, pp 261\u2013321","DOI":"10.1016\/bs.acc.2019.07.012"},{"key":"11_CR30","doi-asserted-by":"publisher","unstructured":"Rose-John S (2020) Interleukin-6 signalling in health and disease. F1000Research. 9:F1000 Faculty Rev-13. https:\/\/doi.org\/10.12688\/f1000research.26058.1","DOI":"10.12688\/f1000research.26058.1"},{"key":"11_CR31","doi-asserted-by":"publisher","unstructured":"Laron Z (2004) IGF-1 and insulin as growth hormones. Biology of IGF\u20101: its interaction with insulin in health and malignant states. 56\u201383. https:\/\/doi.org\/10.1002\/0470869976.ch5","DOI":"10.1002\/0470869976.ch5"},{"issue":"8","key":"11_CR32","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0021-9258(17)40889-1","volume":"253","author":"E Rinderknecht","year":"1978","unstructured":"Rinderknecht E, Humbel RE (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253(8):2769\u20132776","journal-title":"J Biol Chem"},{"issue":"4","key":"11_CR33","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2014.10.029","volume":"159","author":"A Hawley John","year":"2014","unstructured":"Hawley John A, Hargreaves M, Joyner Michael J, Zierath JR (2014) Integrative biology of exercise. Cell 159(4):738\u2013749. https:\/\/doi.org\/10.1016\/j.cell.2014.10.029","journal-title":"Cell"},{"issue":"5","key":"11_CR34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2174\/1389202919666180101153911","volume":"19","author":"BM Scicchitano","year":"2018","unstructured":"Scicchitano BM, Dobrowolny G, Sica G, Musar\u00f2 A (2018) Molecular insights into muscle homeostasis atrophy and wasting. Current Genomics 19(5):356\u2013369. https:\/\/doi.org\/10.2174\/1389202919666180101153911","journal-title":"Current Genomics"},{"key":"11_CR35","doi-asserted-by":"publisher","unstructured":"Aldinucci D, Borghese C, Casagrande N (2012) The CCL5\/CCR5 Axis in cancer progression. Cancers (Basel) 12(7). https:\/\/doi.org\/10.3390\/cancers12071765","DOI":"10.3390\/cancers12071765"},{"issue":"11","key":"11_CR36","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1517\/14728222.2014.949238","volume":"18","author":"M Velasco-Velazquez","year":"2014","unstructured":"Velasco-Velazquez M, Xolalpa W, Pestell RG (2014) The potential to target CCL5\/CCR5 in breast cancer. Expert Opin Ther Targets 18(11):1265\u20131275. https:\/\/doi.org\/10.1517\/14728222.2014.949238","journal-title":"Expert Opin Ther Targets"},{"issue":"12","key":"11_CR37","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1517\/14728222.2013.837886","volume":"17","author":"RE Marques","year":"2013","unstructured":"Marques RE, Guabiraba R, Russo RC, Teixeira MM (2013) Targeting CCL5 in inflammation. Expert Opin Ther Targets 17(12):1439\u20131460. https:\/\/doi.org\/10.1517\/14728222.2013.837886","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"11_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jlb.60.1.147","volume":"60","author":"C Combadiere","year":"1996","unstructured":"Combadiere C, Ahuja SK, Tiffany HL, Murphy PM (1996) Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES. J Leukoc Biol 60(1):147\u2013152. https:\/\/doi.org\/10.1002\/jlb.60.1.147","journal-title":"J Leukoc Biol"},{"issue":"29","key":"11_CR39","doi-asserted-by":"publisher","first-page":"17161","DOI":"10.1074\/jbc.271.29.17161","volume":"271","author":"CJ Raport","year":"1996","unstructured":"Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF (1996) Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J Biol Chem 271(29):17161\u201317166. https:\/\/doi.org\/10.1074\/jbc.271.29.17161","journal-title":"J Biol Chem"},{"issue":"11","key":"11_CR40","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1021\/bi952950g","volume":"35","author":"M Samson","year":"1996","unstructured":"Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M (1996) Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35(11):3362\u20133367. https:\/\/doi.org\/10.1021\/bi952950g","journal-title":"Biochemistry"},{"issue":"8","key":"11_CR41","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/j.1582-4934.2011.01482.x","volume":"16","author":"RJ Wierda","year":"2012","unstructured":"Wierda RJ, Kuipers HF, van Eggermond MC, Benard A, van Leeuwen JC, Carluccio S et al (2012) Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors. J Cell Mol Med 16(8):1866\u20131877. https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01482.x","journal-title":"J Cell Mol Med"},{"issue":"12","key":"11_CR42","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.4049\/jimmunol.1201018","volume":"189","author":"E Schlecker","year":"2012","unstructured":"Schlecker E, Stojanovic A, Eisen C, Quack C, Falk CS, Umansky V et al (2012) Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J Immunol 189(12):5602\u20135611. https:\/\/doi.org\/10.4049\/jimmunol.1201018","journal-title":"J Immunol"},{"issue":"1","key":"11_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2013.10.006","volume":"352","author":"P Weitzenfeld","year":"2014","unstructured":"Weitzenfeld P, Ben-Baruch A (2014) The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. Cancer Lett 352(1):36\u201353. https:\/\/doi.org\/10.1016\/j.canlet.2013.10.006","journal-title":"Cancer Lett"},{"issue":"19","key":"11_CR44","doi-asserted-by":"publisher","first-page":"E1960","DOI":"10.1073\/pnas.1322887111","volume":"111","author":"L Martinez-Munoz","year":"2014","unstructured":"Martinez-Munoz L, Barroso R, Dyrhaug SY, Navarro G, Lucas P, Soriano SF et al (2014) CCR5\/CD4\/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface. Proc Natl Acad Sci U S A 111(19):E1960\u2013E1969. https:\/\/doi.org\/10.1073\/pnas.1322887111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"11_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s0092-8674(00)80110-5","volume":"86","author":"R Liu","year":"1996","unstructured":"Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R et al (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86(3):367\u2013377. https:\/\/doi.org\/10.1016\/s0092-8674(00)80110-5","journal-title":"Cell"},{"issue":"6593","key":"11_CR46","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/382722a0","volume":"382","author":"M Samson","year":"1996","unstructured":"Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM et al (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382(6593):722\u2013725. https:\/\/doi.org\/10.1038\/382722a0","journal-title":"Nature"},{"issue":"6","key":"11_CR47","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1086\/301645","volume":"61","author":"M Carrington","year":"1997","unstructured":"Carrington M, Kissner T, Gerrard B, Ivanov S, O\u2019Brien SJ, Dean M (1997) Novel alleles of the chemokine-receptor gene CCR5. Am J Hum Genet 61(6):1261\u20131267. https:\/\/doi.org\/10.1086\/301645","journal-title":"Am J Hum Genet"},{"issue":"3","key":"11_CR48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0797-221","volume":"16","author":"MA Ansari-Lari","year":"1997","unstructured":"Ansari-Lari MA, Liu XM, Metzker ML, Rut AR, Gibbs RA (1997) The extent of genetic variation in the CCR5 gene. Nat Genet 16(3):221\u2013222. https:\/\/doi.org\/10.1038\/ng0797-221","journal-title":"Nat Genet"},{"issue":"3","key":"11_CR49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/ncpneph0418","volume":"3","author":"AM Krensky","year":"2007","unstructured":"Krensky AM, Ahn YT (2007) Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat Clin Pract Nephrol 3(3):164\u2013170. https:\/\/doi.org\/10.1038\/ncpneph0418","journal-title":"Nat Clin Pract Nephrol"},{"issue":"1","key":"11_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","volume":"9","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Lan T, Wei Y, Wei X (2022) CCL5\/CCR5 axis in human diseases and related treatments. Genes Dis 9(1):12\u201327. https:\/\/doi.org\/10.1016\/j.gendis.2021.08.004","journal-title":"Genes Dis"},{"issue":"11","key":"11_CR51","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1172\/JCI41732","volume":"120","author":"ML Berres","year":"2010","unstructured":"Berres ML, Koenen RR, Rueland A, Zaldivar MM, Heinrichs D, Sahin H et al (2010) Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J Clin Invest 120(11):4129\u20134140. https:\/\/doi.org\/10.1172\/JCI41732","journal-title":"J Clin Invest"},{"key":"11_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cyto.2018.03.012","volume":"108","author":"Y Ishiuchi","year":"2018","unstructured":"Ishiuchi Y, Sato H, Komatsu N, Kawaguchi H, Matsuwaki T, Yamanouchi K et al (2018) Identification of CCL5\/RANTES as a novel contraction-reducible myokine in mouse skeletal muscle. Cytokine 108:17\u201323. https:\/\/doi.org\/10.1016\/j.cyto.2018.03.012","journal-title":"Cytokine"},{"issue":"5","key":"11_CR53","doi-asserted-by":"publisher","first-page":"E1191","DOI":"10.1152\/ajpendo.90280.2008","volume":"295","author":"T Nedachi","year":"2008","unstructured":"Nedachi T, Fujita H, Kanzaki M (2008) Contractile C2C12 myotube model for studying exercise-inducible responses in skeletal muscle. Am J Physiol Endocrinol Metab 295(5):E1191\u2013E1204. https:\/\/doi.org\/10.1152\/ajpendo.90280.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"11_CR54","doi-asserted-by":"publisher","first-page":"695","DOI":"10.4103\/ijem.IJEM_146_17","volume":"21","author":"S Bajaj","year":"2017","unstructured":"Bajaj S, Kashyap R, Srivastava A, Singh S (2017) Metabolic derangement in acute and chronic liver disorders. Indian J Endocrinol Metab. 21(5):695\u2013698. https:\/\/doi.org\/10.4103\/ijem.IJEM_146_17","journal-title":"Indian J Endocrinol Metab."},{"issue":"10","key":"11_CR55","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00424-018-2167-3","volume":"470","author":"F Campos","year":"2018","unstructured":"Campos F, Abrigo J, Aguirre F, Garces B, Arrese M, Karpen S et al (2018) Sarcopenia in a mice model of chronic liver disease: role of the ubiquitin-proteasome system and oxidative stress. Pflugers Arch 470(10):1503\u20131519. https:\/\/doi.org\/10.1007\/s00424-018-2167-3","journal-title":"Pflugers Arch"},{"issue":"1","key":"11_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/082585971102700105","volume":"27","author":"AA Hope","year":"2011","unstructured":"Hope AA, Morrison RS (2011) Integrating palliative care with chronic liver disease care. J Palliat Care 27(1):20\u201327","journal-title":"J Palliat Care"},{"key":"11_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21037\/tgh-20-236","volume":"7","author":"JS Redman","year":"2022","unstructured":"Redman JS, Kaspar M, Puri P (2022) Implications of pre-transplant sarcopenia and frailty in patients with non-alcoholic steatohepatitis and alcoholic liver disease. Transl Gastroenterol Hepatol 7:29. https:\/\/doi.org\/10.21037\/tgh-20-236","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"3","key":"11_CR58","doi-asserted-by":"publisher","first-page":"196","DOI":"10.21037\/hbsn.2017.03.10","volume":"6","author":"H Uchiyama","year":"2017","unstructured":"Uchiyama H (2017) Sarcopenia in liver transplant recipients: its relevance to peritransplant morbidity and mortality. Hepatobiliary Surg Nutr. 6(3):196\u2013199. https:\/\/doi.org\/10.21037\/hbsn.2017.03.10","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"3","key":"11_CR59","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.rgmx.2016.10.002","volume":"82","author":"R Zubieta-Rodriguez","year":"2017","unstructured":"Zubieta-Rodriguez R, Gomez-Correa J, Rodriguez-Amaya R, Ariza-Mejia KA, Toloza-Cuta NA (2017) Hospital mortality in cirrhotic patients at a tertiary care center. Rev Gastroenterol Mex 82(3):203\u2013209. https:\/\/doi.org\/10.1016\/j.rgmx.2016.10.002","journal-title":"Rev Gastroenterol Mex"},{"issue":"1","key":"11_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajem.2015.09.004","volume":"34","author":"RO Ximenes","year":"2016","unstructured":"Ximenes RO, Farias AQ, Scalabrini Neto A, Diniz MA, Kubota GT, Ivo MM et al (2016) Patients with cirrhosis in the ED: early predictors of infection and mortality. Am J Emerg Med 34(1):25\u201329. https:\/\/doi.org\/10.1016\/j.ajem.2015.09.004","journal-title":"Am J Emerg Med"},{"issue":"1","key":"11_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2011.06.024","volume":"56","author":"E Levesque","year":"2012","unstructured":"Levesque E, Hoti E, Azoulay D, Ichai P, Habouchi H, Castaing D et al (2012) Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 56(1):95\u2013102. https:\/\/doi.org\/10.1016\/j.jhep.2011.06.024","journal-title":"J Hepatol"},{"key":"11_CR62","doi-asserted-by":"publisher","first-page":"1617805","DOI":"10.1155\/2020\/1617805","volume":"2020","author":"A Gonzalez","year":"2020","unstructured":"Gonzalez A, Huerta-Salgado C, Orozco-Aguilar J, Aguirre F, Tacchi F, Simon F et al (2020) Role of oxidative stress in hepatic and extrahepatic dysfunctions during nonalcoholic fatty liver disease (NAFLD). Oxid Med Cell Longev 2020:1617805. https:\/\/doi.org\/10.1155\/2020\/1617805","journal-title":"Oxid Med Cell Longev"},{"issue":"47","key":"11_CR63","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","volume":"23","author":"BJ Perumpail","year":"2017","unstructured":"Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A (2017) Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol 23(47):8263\u20138276. https:\/\/doi.org\/10.3748\/wjg.v23.i47.8263","journal-title":"World J Gastroenterol"},{"key":"11_CR64","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver (2009) EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 51(2):237\u201367. https:\/\/doi.org\/10.1016\/j.jhep.2009.04.009","DOI":"10.1016\/j.jhep.2009.04.009"},{"issue":"3","key":"11_CR65","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/cld.901","volume":"15","author":"MR Pedersen","year":"2020","unstructured":"Pedersen MR, Mayo MJ (2020) Managing the symptoms and complications of cholestasis. Clin Liver Dis (Hoboken) 15(3):120\u2013124. https:\/\/doi.org\/10.1002\/cld.901","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"1","key":"11_CR66","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2174\/1566524019666190917124636","volume":"20","author":"J Abrigo","year":"2019","unstructured":"Abrigo J, Marin T, Aguirre F, Tacchi F, Vilos C, Simon F et al (2019) N-Acetyl cysteine attenuates the sarcopenia and muscle apoptosis induced by chronic liver disease. Curr Mol Med 20(1):60\u201371. https:\/\/doi.org\/10.2174\/1566524019666190917124636","journal-title":"Curr Mol Med"},{"key":"11_CR67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.maturitas.2019.11.007","volume":"132","author":"AJ Cruz-Jentoft","year":"2020","unstructured":"Cruz-Jentoft AJ, Dawson Hughes B, Scott D, Sanders KM, Rizzoli R (2020) Nutritional strategies for maintaining muscle mass and strength from middle age to later life: a narrative review. Maturitas 132:57\u201364. https:\/\/doi.org\/10.1016\/j.maturitas.2019.11.007","journal-title":"Maturitas"},{"issue":"7\u20138","key":"11_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10354-018-0618-2","volume":"169","author":"KK Sarcopenia","year":"2019","unstructured":"Sarcopenia KK (2019) Wien Med Wochenschr 169(7\u20138):157\u2013172. https:\/\/doi.org\/10.1007\/s10354-018-0618-2","journal-title":"Wien Med Wochenschr"},{"issue":"1","key":"11_CR69","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"key":"11_CR70","doi-asserted-by":"publisher","first-page":"2063179","DOI":"10.1155\/2018\/2063179","volume":"2018","author":"J Abrigo","year":"2018","unstructured":"Abrigo J, Elorza AA, Riedel CA, Vilos C, Simon F, Cabrera D et al (2018) Role of oxidative stress as key regulator of muscle wasting during Cachexia. Oxid Med Cell Longev 2018:2063179. https:\/\/doi.org\/10.1155\/2018\/2063179","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"11_CR71","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/hep.29420","volume":"66","author":"RA Bhanji","year":"2017","unstructured":"Bhanji RA, Narayanan P, Allen AM, Malhi H, Watt KD (2017) Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology (Baltimore, MD) 66(6):2055\u20132065. https:\/\/doi.org\/10.1002\/hep.29420","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"12","key":"11_CR72","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/17474124.2018.1534586","volume":"12","author":"CS Hsu","year":"2018","unstructured":"Hsu CS, Kao JH (2018) Sarcopenia and chronic liver diseases. Expert Rev Gastroenterol Hepatol 12(12):1229\u20131244. https:\/\/doi.org\/10.1080\/17474124.2018.1534586","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"11_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7570\/jomes20017","volume":"29","author":"J Noh","year":"2020","unstructured":"Noh J (2020) Sarcopenia as a novel risk factor for nonalcoholic fatty liver disease. J Obes Metab Syndr 29(1):1\u20133. https:\/\/doi.org\/10.7570\/jomes20017","journal-title":"J Obes Metab Syndr"},{"issue":"10","key":"11_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186990","volume":"12","author":"G Kim","year":"2017","unstructured":"Kim G, Kang SH, Kim MY, Baik SK (2017) Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis. PLoS ONE 12(10):e0186990. https:\/\/doi.org\/10.1371\/journal.pone.0186990","journal-title":"PLoS ONE"},{"key":"11_CR75","doi-asserted-by":"publisher","unstructured":"De Bandt JP, Jegatheesan P, Tennoune-El-Hafaia N (2018) Muscle loss in chronic liver diseases: the example of nonalcoholic liver disease. Nutrients 10(9). https:\/\/doi.org\/10.3390\/nu10091195","DOI":"10.3390\/nu10091195"},{"issue":"10","key":"11_CR76","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00535-019-01605-6","volume":"54","author":"M Ebadi","year":"2019","unstructured":"Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ (2019) Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol 54(10):845\u2013859. https:\/\/doi.org\/10.1007\/s00535-019-01605-6","journal-title":"J Gastroenterol"},{"key":"11_CR77","doi-asserted-by":"publisher","unstructured":"Cabrera D, Cabello-Verrugio C, Sol\u00eds N, Mart\u00edn DS, Cofr\u00e9 C, Pizarro M et al (2018) Somatotropic axis dysfunction in non-alcoholic fatty liver disease: beneficial hepatic and systemic effects of hormone supplementation. Int J Mol Sci 19(5). https:\/\/doi.org\/10.3390\/ijms19051339","DOI":"10.3390\/ijms19051339"},{"key":"11_CR78","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clnesp.2017.08.005","volume":"22","author":"AC Meeks","year":"2017","unstructured":"Meeks AC, Madill J (2017) Sarcopenia in liver transplantation: a review. Clin Nutr ESPEN 22:76\u201380. https:\/\/doi.org\/10.1016\/j.clnesp.2017.08.005","journal-title":"Clin Nutr ESPEN"},{"issue":"11","key":"11_CR79","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/lt.23724","volume":"19","author":"A DiMartini","year":"2013","unstructured":"DiMartini A, Cruz RJ Jr, Dew MA, Myaskovsky L, Goodpaster B, Fox K et al (2013) Muscle mass predicts outcomes following liver transplantation. Liver Transpl 19(11):1172\u20131180. https:\/\/doi.org\/10.1002\/lt.23724","journal-title":"Liver Transpl"},{"issue":"2","key":"11_CR80","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/lt.24671","volume":"23","author":"N Golse","year":"2017","unstructured":"Golse N, Bucur PO, Ciacio O, Pittau G, Sa Cunha A, Adam R et al (2017) A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation. Liver Transpl 23(2):143\u2013154. https:\/\/doi.org\/10.1002\/lt.24671","journal-title":"Liver Transpl"},{"issue":"1","key":"11_CR81","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/jcsm.12095","volume":"8","author":"M Kalafateli","year":"2017","unstructured":"Kalafateli M, Mantzoukis K, Choi Yau Y, Mohammad AO, Arora S, Rodrigues S et al (2017) Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the model for end-stage liver disease score. J Cachexia Sarcopenia Muscle 8(1):113\u2013121. https:\/\/doi.org\/10.1002\/jcsm.12095","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"11_CR82","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/lt.25591","volume":"25","author":"PH Ooi","year":"2019","unstructured":"Ooi PH, Hager A, Mazurak VC, Dajani K, Bhargava R, Gilmour SM et al (2019) Sarcopenia in chronic liver disease: impact on outcomes. Liver Transpl 25(9):1422\u20131438. https:\/\/doi.org\/10.1002\/lt.25591","journal-title":"Liver Transpl"},{"issue":"6","key":"11_CR83","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","volume":"65","author":"S Dasarathy","year":"2016","unstructured":"Dasarathy S, Merli M (2016) Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol 65(6):1232\u20131244. https:\/\/doi.org\/10.1016\/j.jhep.2016.07.040","journal-title":"J Hepatol"},{"issue":"3","key":"11_CR84","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.29602","volume":"67","author":"M Praktiknjo","year":"2018","unstructured":"Praktiknjo M, Book M, Luetkens J, Pohlmann A, Meyer C, Thomas D et al (2018) Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology 67(3):1014\u20131026. https:\/\/doi.org\/10.1002\/hep.29602","journal-title":"Hepatology"},{"key":"11_CR85","doi-asserted-by":"publisher","unstructured":"Son SW, Song DS, Chang UI, Yang JM (2021) Definition of sarcopenia in chronic liver disease. Life (Basel) 11(4). https:\/\/doi.org\/10.3390\/life11040349","DOI":"10.3390\/life11040349"},{"issue":"3","key":"11_CR86","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3350\/cmh.2019.0015","volume":"25","author":"A Jindal","year":"2019","unstructured":"Jindal A, Jagdish RK (2019) Sarcopenia: Ammonia metabolism and hepatic encephalopathy. Clin Mol Hepatol 25(3):270\u2013279. https:\/\/doi.org\/10.3350\/cmh.2019.0015","journal-title":"Clin Mol Hepatol"},{"issue":"10","key":"11_CR87","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s40279-016-0486-0","volume":"46","author":"TJ Suchomel","year":"2016","unstructured":"Suchomel TJ, Nimphius S, Stone MH (2016) The importance of muscular strength in athletic performance. Sports Med 46(10):1419\u20131449. https:\/\/doi.org\/10.1007\/s40279-016-0486-0","journal-title":"Sports Med"},{"issue":"4","key":"11_CR88","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/ajcn\/36.4.680","volume":"36","author":"SB Heymsfield","year":"1982","unstructured":"Heymsfield SB, McManus C, Smith J, Stevens V, Nixon DW (1982) Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr 36(4):680\u2013690. https:\/\/doi.org\/10.1093\/ajcn\/36.4.680","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"11_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-019-00545-w","volume":"105","author":"C Beaudart","year":"2019","unstructured":"Beaudart C, Rolland Y, Cruz-Jentoft AJ, Bauer JM, Sieber C, Cooper C et al (2019) Assessment of muscle function and physical performance in daily clinical practice: a position paper endorsed by the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Calcif Tissue Int 105(1):1\u201314. https:\/\/doi.org\/10.1007\/s00223-019-00545-w","journal-title":"Calcif Tissue Int"},{"issue":"10191","key":"11_CR90","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet 393(10191):2636\u20132646. https:\/\/doi.org\/10.1016\/S0140-6736(19)31138-9","journal-title":"Lancet"},{"key":"11_CR91","doi-asserted-by":"publisher","unstructured":"Aguirre F, Abrigo J, Gonzalez F, Gonzalez A, Simon F, Cabello-Verrugio C (2020) Protective effect of angiotensin 1\u20137 on sarcopenia induced by chronic liver disease in mice. Int J Mol Sci 21(11). https:\/\/doi.org\/10.3390\/ijms21113891","DOI":"10.3390\/ijms21113891"},{"key":"11_CR92","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bone.2019.03.033","volume":"123","author":"BC Collins","year":"2019","unstructured":"Collins BC, Laakkonen EK, Lowe DA (2019) Aging of the musculoskeletal system: how the loss of estrogen impacts muscle strength. Bone 123:137\u2013144. https:\/\/doi.org\/10.1016\/j.bone.2019.03.033","journal-title":"Bone"},{"issue":"2","key":"11_CR93","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11938-014-0016-9","volume":"12","author":"S Dasarathy","year":"2014","unstructured":"Dasarathy S (2014) Treatment to improve nutrition and functional capacity evaluation in liver transplant candidates. Curr Treat Options Gastroenterol 12(2):242\u2013255. https:\/\/doi.org\/10.1007\/s11938-014-0016-9","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"1","key":"11_CR94","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/jcp.29839","volume":"236","author":"J Abrigo","year":"2021","unstructured":"Abrigo J, Gonzalez F, Aguirre F, Tacchi F, Gonzalez A, Meza MP et al (2021) Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor. J Cell Physiol 236(1):260\u2013272. https:\/\/doi.org\/10.1002\/jcp.29839","journal-title":"J Cell Physiol"},{"key":"11_CR95","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.69533","author":"LVHN Clerbaux","year":"2017","unstructured":"Clerbaux LVHN, Gouw A, Manco R et al (2017) Relevance of the CDE and DDC mouse models to study ductular reaction in chronic human liver diseases. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.69533","journal-title":"IntechOpen"},{"issue":"2","key":"11_CR96","doi-asserted-by":"publisher","first-page":"G81","DOI":"10.1152\/ajpgi.00065.2015","volume":"310","author":"AY Dossa","year":"2016","unstructured":"Dossa AY, Escobar O, Golden J, Frey MR, Ford HR, Gayer CP (2016) Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling. Am J Physiol Gastrointest Liver Physiol 310(2):G81-92. https:\/\/doi.org\/10.1152\/ajpgi.00065.2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"11_CR97","doi-asserted-by":"publisher","first-page":"4847941","DOI":"10.1155\/2021\/4847941","volume":"2021","author":"J Orozco-Aguilar","year":"2021","unstructured":"Orozco-Aguilar J, Simon F, Cabello-Verrugio C (2021) Redox-Dependent effects in the physiopathological role of bile acids. Oxid Med Cell Longev 2021:4847941. https:\/\/doi.org\/10.1155\/2021\/4847941","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"11_CR98","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","volume":"178","author":"K Allen","year":"2011","unstructured":"Allen K, Jaeschke H, Copple BL (2011) Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol 178(1):175\u2013186. https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.026","journal-title":"Am J Pathol"},{"issue":"5","key":"11_CR99","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1006\/bbrc.2001.5893","volume":"288","author":"F Hirano","year":"2001","unstructured":"Hirano F, Kobayashi A, Hirano Y, Nomura Y, Fukawa E, Makino I (2001) Bile acids regulate RANTES gene expression through its cognate NF-kappaB binding sites. Biochem Biophys Res Commun 288(5):1095\u20131101. https:\/\/doi.org\/10.1006\/bbrc.2001.5893","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"11_CR100","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2353\/ajpath.2007.061133","volume":"171","author":"P Fickert","year":"2007","unstructured":"Fickert P, Stoger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH et al (2007) A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 171(2):525\u2013536. https:\/\/doi.org\/10.2353\/ajpath.2007.061133","journal-title":"Am J Pathol"},{"key":"11_CR101","doi-asserted-by":"publisher","unstructured":"Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR (1992) Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 153(1\u20132):115\u201324. https:\/\/doi.org\/10.1016\/0022-1759(92)90313-i","DOI":"10.1016\/0022-1759(92)90313-i"},{"issue":"1","key":"11_CR102","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/gast.2001.25542","volume":"121","author":"P Fickert","year":"2001","unstructured":"Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Pojer C, Zenz R et al (2001) Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 121(1):170\u2013183. https:\/\/doi.org\/10.1053\/gast.2001.25542","journal-title":"Gastroenterology"},{"issue":"8","key":"11_CR103","doi-asserted-by":"publisher","first-page":"E1018","DOI":"10.1152\/ajpendo.00227.2013","volume":"305","author":"CB Tanner","year":"2013","unstructured":"Tanner CB, Madsen SR, Hallowell DM, Goring DM, Moore TM, Hardman SE et al (2013) Mitochondrial and performance adaptations to exercise training in mice lacking skeletal muscle LKB1. Am J Physiol Endocrinol Metab 305(8):E1018\u2013E1029. https:\/\/doi.org\/10.1152\/ajpendo.00227.2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"11_CR104","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/bonekey.2015.101","volume":"4","author":"A Bonetto","year":"2015","unstructured":"Bonetto A, Andersson DC, Waning DL (2015) Assessment of muscle mass and strength in mice. Bonekey Rep. 4:732. https:\/\/doi.org\/10.1038\/bonekey.2015.101","journal-title":"Bonekey Rep."},{"key":"11_CR105","doi-asserted-by":"publisher","unstructured":"Aartsma-Rus A, van Putten M (2014) Assessing functional performance in the mdx mouse model. J Vis Exp (85). https:\/\/doi.org\/10.3791\/51303","DOI":"10.3791\/51303"},{"key":"11_CR106","doi-asserted-by":"publisher","unstructured":"Aravena J, Abrigo J, Gonzalez F, Aguirre F, Gonzalez A, Simon F, et al. Angiotensin (1\u20137) Decreases myostatin-induced NF-kappaB signaling and skeletal muscle atrophy. Int J Mol Sci 21(3). https:\/\/doi.org\/10.3390\/ijms21031167","DOI":"10.3390\/ijms21031167"},{"issue":"4","key":"11_CR107","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1242\/dmm.023390","volume":"9","author":"MG Morales","year":"2016","unstructured":"Morales MG, Abrigo J, Acuna MJ, Santos RA, Bader M, Brandan E et al (2016) Angiotensin-(1\u20137) attenuates disuse skeletal muscle atrophy in mice via its receptor Mas. Disease Models Mech 9(4):441\u2013449. https:\/\/doi.org\/10.1242\/dmm.023390","journal-title":"Disease Models Mech"},{"key":"11_CR108","doi-asserted-by":"publisher","unstructured":"Abrigo J, Campos F, Gonzalez F, Aguirre F, Gonzalez A, Huerta-Salgado C et al (2020) Sarcopenia induced by chronic liver disease in mice requires the expression of the bile acids membrane receptor TGR5. Int J Mol Sci 21(21). https:\/\/doi.org\/10.3390\/ijms21217922","DOI":"10.3390\/ijms21217922"},{"key":"11_CR109","unstructured":"Laure-Alix C (2018) Relevance of the CDE and DDC mouse models to study ductular reaction in chronic human liver diseases. IntechOpen. https:\/\/www.intechopen.com\/books\/experimental-animal-models-of-human-diseases-an-effective-therapeutic-strategy\/relevance-of-the-cde-and-ddc-mouse-models-to-study-ductular-reaction-in-chronic-human-liver-diseases. Accessed"},{"issue":"7","key":"11_CR110","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41423-019-0279-0","volume":"17","author":"M Li","year":"2020","unstructured":"Li M, Sun X, Zhao J, Xia L, Li J, Xu M et al (2020) CCL5 deficiency promotes liver repair by improving inflammation resolution and liver regeneration through M2 macrophage polarization. Cell Mol Immunol 17(7):753\u2013764. https:\/\/doi.org\/10.1038\/s41423-019-0279-0","journal-title":"Cell Mol Immunol"},{"key":"11_CR111","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/860565","volume":"2009","author":"A Demoule","year":"2009","unstructured":"Demoule A, Divangahi M, Yahiaoui L, Danialou G, Gvozdic D, Petrof BJ (2009) Chemokine receptor and ligand upregulation in the diaphragm during endotoxemia and Pseudomonas lung infection. Mediators Inflamm 2009:860565. https:\/\/doi.org\/10.1155\/2009\/860565","journal-title":"Mediators Inflamm"},{"key":"11_CR112","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-981-13-1435-3_12","volume":"1088","author":"A Thoma","year":"2018","unstructured":"Thoma A, Lightfoot AP (2018) NF-kB and Inflammatory Cytokine signalling: role in skeletal muscle atrophy. Adv Exp Med Biol 1088:267\u2013279. https:\/\/doi.org\/10.1007\/978-981-13-1435-3_12","journal-title":"Adv Exp Med Biol"},{"key":"11_CR113","doi-asserted-by":"publisher","unstructured":"Martin AI, Gomez-SanMiguel AB, Priego T, Lopez-Calderon A (2018) Formoterol treatment prevents the effects of endotoxin on muscle TNF\/NF-kB, Akt\/mTOR, and proteolytic pathways in a rat model. Role of IGF-I and miRNA 29b. Am J Physiol Endocrinol Metab 315(4):E705-E14. https:\/\/doi.org\/10.1152\/ajpendo.00043.2018","DOI":"10.1152\/ajpendo.00043.2018"},{"issue":"3","key":"11_CR114","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1210\/me.2013-1179","volume":"28","author":"S Sriram","year":"2014","unstructured":"Sriram S, Subramanian S, Juvvuna PK, Ge X, Lokireddy S, McFarlane CD et al (2014) Myostatin augments muscle-specific ring finger protein-1 expression through an NF-kB independent mechanism in SMAD3 null muscle. Mol Endocrinol 28(3):317\u2013330. https:\/\/doi.org\/10.1210\/me.2013-1179","journal-title":"Mol Endocrinol"}],"container-title":["Advances in Experimental Medicine and Biology","Advances in Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-26163-3_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:06:23Z","timestamp":1682323583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-26163-3_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031261626","9783031261633"],"references-count":114,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-26163-3_11","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"25 April 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}